TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.005

-1.3%

2:22 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 9wald9 who wrote (434)	3/15/2005 1:37:18 PM
From: Mike McFarland	Read Replies (1) of 557

freshpatents.com "As described herein, doxorubicin, an approved antibiotic, also enhances rAAV transduction. Doxorubin may facilitate viral binding to the proteasome and/or subsequent transportation into the nucleus" Only reason I snipped that out is because it came up six months ago on Yahoo board, and happened to recognize it again. Cross posted over there, fwiw.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next